Methods are provided for use in treating humans suffering from irritable bowel syndrome. In the subject methods, an effective amount of a nerve-acting agent, e.g., lidocaine, topiramate, mexiletine and gabapentin, etc., is administered to a human suffering from irritable bowel syndrome. Also provided...http://www.google.com.au/patents/US7750046?utm_source=gb-gplus-sharePatent US7750046 - Treatment of symptoms associated with irritable bowel syndrome